top of page

Cannabinoid Clinic: THCV

Updated: Mar 24, 2023

This article is brought to you by the new Higher Learning LV Core Cannabis course.

 

Welcome to homework assignment 1.21 of the Core Cannabis Lite Track from Higher Learning LV. When you complete this assignment, simply click the link at the bottom of the article to return to the master page for this training track.

 

Welcome to Cannabinoid Clinic, an education project powered by Higher Learning LV. This series provides cannabis and hemp industry professionals with easily digested cannabinoid profiles that ask little of your time—but provide plenty of science-based information.


There are two categories of cannabinoids: Phytocannabinoids and endocannabinoids. Phytocannabinoids are those produced by cannabis/marijuana/hemp, while endocannabinoids are made by the human body. This series covers both.

THCV molecular structure


What is THCV?

Tetrahydrocannabivarin (THCV) is the result of THCVA, the varin-specific acidic precursor for this cannabinoid (stay tuned for more about varins below). First discovered in 1971, it is a peculiar psychoactive cannabinoid for which considerably less research has been conducted than for its chemical cousin delta-9 THC. The most notable characteristic of THCV is that it causes a decrease in appetite.


THCV is considered a minor cannabinoid because it is typically present in low volumes in loose-leaf and other cannabis products. It is most common in examples of the cannabis plant that are considered sativa in nature, conveying energy, creativity, mental stimulation, and clarity.


"In potent doses, however, THCV is significantly psychoactive; many anecdotal testimonies claim even moreso than delta-9 THC."

In low doses, THCV is not only non-psychoactive, but actually acts as a buffer to the psychotropic effects of delta-9 THC (similar to how cannabidiol, or CBD, performs this same role). In potent doses, however, THCV is significantly psychoactive; many anecdotal testimonies claim even moreso than delta-9 THC. Researchers claim that the psychoactivity resulting from THCV features a shorter onset period than delta-9 THC, but also does not last as long.

Like many other cannabinoids and terpenes, THCV has been shown to deliver reductions in inflammation, making it of potential value to literally dozens of conditions and disorders. Antioxidative properties may make this cannabinoid of value in the treatment of diseases such as Parkinson's.

Example of a THCV-rich product


To see the Fast Facts and Research Studies sections that have been removed from this no-cost training asset, enroll in Core Cannabis.

 

Return to the Core Cannabis Lite Track master page.


Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.

197 views0 comments

Recent Posts

See All

Commentaires


bottom of page